Skip to main content
Sign In

Madeleine Kane, MD, PhD

Professor, Division of Medical Oncology

Fred HirschMadeline Kane, MD, PhD



University of Miami Medical School, Miami, FL – 1978
Dr. Kane joined the University of Colorado as full-time faculty in October of 1985.

Dr. Kane’s focus is on clinical studies in Head and Neck, GI and Thyroid cancer research. A priority in her career continues to be ensuring that medical students, residents and fellows, and junior faculty members identify their career focus and successfully pursue it through cancer research training grants. She is the Medical Director of the UCCC Clinical Investigations Core (CIC) where she oversees all clinical research studies and the management of its day-to-day activities.           

Willey CD, Kane MA, Cmelak AJ (2007) A Phase II Trial of Chemoradiation using Docetaxel and Erythropoietin for high risk post operative Head and Neck Cancer Patients. Intl J Radiation Oncology Biology and Physics: 1:67(5) 1324-31. Pervez H and Kane MA (2007) Chemotherapy-induced Neutropenia. Federal Practitioner.

Ballonoff A, Kavanagh D, McCarter M, Kane M, Pearlman N, Nash R, Shah RJ, Schefter, TE (2007) A Phase II trial of Preoperative Capecitabine and Accelerated Intensity Modulated Radiotherapy in Locally Advanced Rectal Cancer. JCO In press.

Chen C, Kane MA, Song J, Campana J, Raben A, Hu K, Harrison L, Quon H, Dancey J, Baron A, Said S, Eckhardt SG, and Raben D (2007) A Phase I Trial of Gefitnib in combination with Radiation or Chemoradiation for Patients with Locally Advanced Squamous Cell Head and Neck Cancer. JCO. In press.